Cargando…

Isolated Cognitive Decline in Neurologically Stable Patients with Multiple Sclerosis

(1) Background: Cognitive deterioration is an important marker of disease activity in multiple sclerosis (MS). It is vital to detect cognitive decline as soon as possible. Cognitive deterioration can take the form of isolated cognitive decline (ICD) with no other clinical signs of disease progressio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Motyl, Jiri, Friedova, Lucie, Vaneckova, Manuela, Krasensky, Jan, Lorincz, Balazs, Blahova Dusankova, Jana, Andelova, Michaela, Fuchs, Tom A., Kubala Havrdova, Eva, Benedict, Ralph H. B., Horakova, Dana, Uher, Tomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999620/ https://www.ncbi.nlm.nih.gov/pubmed/33800075 http://dx.doi.org/10.3390/diagnostics11030464

Ejemplares similares

Additive Effect of Spinal Cord Volume, Diffuse and Focal Cord Pathology on Disability in Multiple Sclerosis
por: Andelova, Michaela, et al.
Publicado: (2019)

Cognitive clinico‐radiological paradox in early stages of multiple sclerosis
por: Uher, Tomas, et al.
Publicado: (2017)

Natalizumab Induces Changes of Cerebrospinal Fluid Measures in Multiple Sclerosis
por: Ganapathy Subramanian, Ranjani, et al.
Publicado: (2021)

Brainstem lesions are associated with diffuse spinal cord involvement in early multiple sclerosis
por: Andelova, Michaela, et al.
Publicado: (2022)

Validation of the Czech Version of the Dysphagia in Multiple Sclerosis Questionnaire (DYMUS)
por: Novotná, Klára, et al.
Publicado: (2022)

Diagnostic delay of multiple sclerosis: prevalence, determinants and consequences
por: Uher, Tomas, et al.
Publicado: (2023)

Periventricular gradient of T(1) tissue alterations in multiple sclerosis
por: Vaneckova, Manuela, et al.
Publicado: (2022)

Evolution of Brain Volume Loss Rates in Early Stages of Multiple Sclerosis
por: Uher, Tomas, et al.
Publicado: (2021)

Volumetric MRI Markers and Predictors of Disease Activity in Early Multiple Sclerosis: A Longitudinal Cohort Study
por: Kalincik, Tomas, et al.
Publicado: (2012)

MRI correlates of disability progression in patients with CIS over 48 months
por: Uher, Tomas, et al.
Publicado: (2014)

Gray matter atrophy patterns in multiple sclerosis: A 10-year source-based morphometry study
por: Bergsland, Niels, et al.
Publicado: (2017)

Validating atlas-based lesion disconnectomics in multiple sclerosis: A retrospective multi-centric study
por: Ravano, Veronica, et al.
Publicado: (2021)

Clinical correlates of grey matter pathology in multiple sclerosis
por: Horakova, Dana, et al.
Publicado: (2012)

Monitoring of radiologic disease activity by serum neurofilaments in MS
por: Uher, Tomas, et al.
Publicado: (2020)

Lexical and syntactic deficits analyzed via automated natural language processing: the new monitoring tool in multiple sclerosis
por: Šubert, Martin, et al.
Publicado: (2023)

Oxidative Stress Markers in Cerebrospinal Fluid of Newly Diagnosed Multiple Sclerosis Patients and Their Link to Iron Deposition and Atrophy
por: Burgetova, Andrea, et al.
Publicado: (2022)

Establishing pathological cut-offs for lateral ventricular volume expansion rates
por: Dwyer, Michael G., et al.
Publicado: (2018)

Bimonthly Evolution of Cortical Atrophy in Early Relapsing-Remitting Multiple Sclerosis over 2 Years: A Longitudinal Study
por: Zivadinov, Robert, et al.
Publicado: (2013)

Neurological software tool for reliable atrophy measurement (NeuroSTREAM) of the lateral ventricles on clinical-quality T2-FLAIR MRI scans in multiple sclerosis
por: Dwyer, Michael G., et al.
Publicado: (2017)

CSF Markers of Oxidative Stress Are Associated with Brain Atrophy and Iron Accumulation in a 2-Year Longitudinal Cohort of Early MS
por: Burgetova, Andrea, et al.
Publicado: (2023)

Deep Gray Matter Iron Content in Neuromyelitis Optica and Multiple Sclerosis
por: Pudlac, Adam, et al.
Publicado: (2020)

To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection
por: Stastna, Dominika, et al.
Publicado: (2022)

Corrigendum to ’To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection’[Multiple sclerosis and related disorders vol. 65 (2022) 104014]
por: Stastna, Dominika, et al.
Publicado: (2023)

Peripheral blood lymphocytes immunophenotyping predicts disease activity in clinically isolated syndrome patients
por: Posová, Helena, et al.
Publicado: (2017)

Do eyes with and without optic neuritis in multiple sclerosis age equally?
por: Lizrova Preiningerova, Jana, et al.
Publicado: (2018)

Reliable measurements of brain atrophy in individual patients with multiple sclerosis
por: Smeets, Dirk, et al.
Publicado: (2016)

Environmental Factors Associated with Disease Progression after the First Demyelinating Event: Results from the Multi-Center SET Study
por: Horakova, Dana, et al.
Publicado: (2013)

Steroid Sulfation in Neurodegenerative Diseases
por: Vitku, Jana, et al.
Publicado: (2022)

Understanding the positive benefit:risk profile of alemtuzumab in relapsing multiple sclerosis: perspectives from the Alemtuzumab Clinical Development Program
por: Havrdova, Eva, et al.
Publicado: (2017)

Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab
por: Nytrova, Petra, et al.
Publicado: (2023)

Factors influencing daily treatment choices in multiple sclerosis: practice guidelines, biomarkers and burden of disease
por: Berger, Thomas, et al.
Publicado: (2020)

Real-Life Outcome in Multiple Sclerosis in the Czech Republic
por: Kobelt, Gisela, et al.
Publicado: (2019)

Flow Cytometry Analysis of Blood Large Extracellular Vesicles in Patients with Multiple Sclerosis Experiencing Relapse of the Disease
por: Soukup, Jakub, et al.
Publicado: (2022)

The potential of serum neurofilament as biomarker for multiple sclerosis
por: Bittner, Stefan, et al.
Publicado: (2021)

Early Indications of Future Cognitive Decline: Stable versus Declining Controls
por: Rizk-Jackson, Angela, et al.
Publicado: (2013)

Multiple Sclerosis Relapses Following Cessation of Fingolimod
por: Malpas, Charles B., et al.
Publicado: (2022)

Air-stable superparamagnetic metal nanoparticles entrapped in graphene oxide matrix
por: Tuček, Jiří, et al.
Publicado: (2016)

Brain biopsy in neurologic decline of unknown etiology
por: Magaki, Shino, et al.
Publicado: (2014)

MxA mRNA decrease preceding NAb detection in IFNβ‐treated MS patients
por: Libertinova, Jana, et al.
Publicado: (2017)

Author Correction: Air-stable superparamagnetic metal nanoparticles entrapped in graphene oxide matrix
por: Tuček, Jiří, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jhc26t20pmgut9b606sh156ooq